Package Leaflet: Information for the User
Galvus 50mg tablets
vildagliptin
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information:
The active substance of Galvus, vildagliptin, belongs to a group of medicines called «oral antidiabetics».
Galvus is used to treat adult patients with type 2 diabetes when diabetes cannot be controlled by diet and exercise alone. It helps to control blood sugar levels. Your doctor will prescribe Galvus alone or in combination with other antidiabetic medicines that you are already taking if they are not sufficiently effective to control your diabetes.
Type 2 diabetes occurs when the body does not produce enough insulin or when the insulin produced does not work properly. It can also occur when the body produces too much glucagon.
Insulin is a substance that helps to lower blood sugar levels, especially after meals. Glucagon is a substance that promotes the production of sugar by the liver and increases blood sugar levels. Both substances are produced in the pancreas.
How Galvus works
Galvus stimulates the pancreas to produce more insulin and less glucagon. This helps to control blood sugar levels. This medicine has been shown to reduce blood sugar, which will help to prevent complications of your diabetes. Although you start taking this medicine for your diabetes, it is important that you continue with the diet and/or exercise that your doctor has recommended.
Do not take Galvus
Warnings and precautions
Consult your doctor, pharmacist, or nurse before taking Galvus
If you have previously taken vildagliptina but had to stop taking it due to liver disease, you should not take this medicine.
Skin lesions are common complications of diabetes. Follow your doctor's or nurse's recommendations for skin and foot care, paying special attention to the appearance of blisters or ulcers while taking Galvus. If this occurs, you should consult your doctor as soon as possible.
Liver function tests should be performed before starting treatment with Galvus, at intervals of three months during the first year, and periodically thereafter. This is done to detect any signs of increased liver enzymes (transaminases) as soon as possible.
Children and adolescents
The administration of Galvus is not recommended in children and adolescents under 18 years of age.
Use of Galvus with other medicines
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
Your doctor may change your dose of Galvus if you are taking other medicines such as:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Do not use Galvus during pregnancy. It is not known if Galvus passes into breast milk. Do not take Galvus if you are breastfeeding or plan to breastfeed.
Driving and using machines
If you feel dizzy while taking Galvus, do not drive or operate tools or machines.
Galvus contains lactose
Galvus contains lactose (milk sugar). If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.
Galvus contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
How much to take and when
The dose of Galvus that you should take varies depending on your condition. Your doctor will tell you exactly how many Galvus tablets to take.
The maximum daily dose is 100 mg.
The recommended dose of Galvus is:
How to take Galvus
Duration of treatment with Galvus
If you take more Galvus than you should
If you have taken too many Galvus tablets or if someone else has taken your medicine, consult your doctor immediately.You may need medical attention. If you have to visit a doctor or go to the nearest hospital, take the package with you.
If you forget to take Galvus
If you forget to take a dose of this medicine, take it as soon as you remember. Then take the next dose at the usual time. If it is almost time for the next dose, skip the missed dose. Do not take a double dose to make up for forgotten doses.
If you stop taking Galvus
Do not stop taking Galvus unless your doctor tells you to. If you have doubts about the duration of treatment with Galvus, consult your doctor.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Some symptoms require immediate medical attention
You should stop taking Galvus and consult your doctor immediately if you experience any of the following side effects:
Other side effects
Some patients experienced the following side effects while taking Galvus:
Since the marketing of this product, the following side effects have also been reported:
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Composition of Galvus
Each tablet contains 50 mg of vildagliptin.
Appearance of the product and pack size
Galvus 50 mg tablets are white to slightly yellowish, flat, round tablets with "NVR" on one side and "FB" on the other.
Galvus 50 mg tablets are available in packs containing 7, 14, 28, 30, 56, 60, 90, 112, 180, or 336 tablets and in multipacks consisting of 3 packs, each containing 112 tablets.
Not all pack sizes may be marketed.
Marketing authorization holder
Novartis Europharm Limited
Vista Building
Elm Park, Merrion Road
Dublin 4
Ireland
Manufacturer
Lek d.d.
Verovskova ulica 57
Ljubljana 1526
Slovenia
Novartis Farmacéutica S.A.
Gran Via de les Corts Catalanes, 764
08013 Barcelona
Spain
Novartis Pharma GmbH
Roonstrasse 25
D-90429 Nuremberg
Germany
Novartis Pharmaceutical Manufacturing LLC
Verovskova ulica 57
Ljubljana 1000
Slovenia
Novartis Pharma GmbH
Sophie-Germain-Strasse 10
90443 Nürnberg
Germany
You can obtain further information on this medicine by contacting the local representative of the marketing authorization holder:
Belgium Novartis Pharma N.V. Tel: +32 2 246 16 11 | Lithuania SIA Novartis Baltics Lietuvos filialas Tel: +370 5 269 16 50 |
Bulgaria Novartis Bulgaria EOOD Tel: +359 2 489 98 28 | Luxembourg Novartis Pharma N.V. Tel: +32 2 246 16 11 |
Czech Republic Novartis s.r.o. Tel: +420 225 775 111 | Hungary Novartis Hungária Kft. Tel: +36 1 457 65 00 |
Denmark Novartis Healthcare A/S Tel: +45 39 16 84 00 | Malta Novartis Pharma Services Inc. Tel: +356 2122 2872 |
Germany Novartis Pharma GmbH Tel: +49 911 273 0 | Netherlands Novartis Pharma B.V. Tel: +31 88 04 52 111 |
Estonia SIA Novartis Baltics Eesti filiaal Tel: +372 66 30 810 | Norway Novartis Norge AS Tel: +47 23 05 20 00 |
Greece Novartis (Hellas) A.E.B.E. Tel: +30 210 281 17 12 | Austria Novartis Pharma GmbH Tel: +43 1 86 6570 |
Spain Novartis Farmacéutica, S.A. Tel: +34 93 306 42 00 | Poland Novartis Poland Sp. z o.o. Tel: +48 22 375 4888 |
France Novartis Pharma S.A.S. Tel: +33 1 55 47 66 00 | Portugal Novartis Farma - Produtos Farmacêuticos, S.A. Tel: +351 21 000 8600 |
Croatia Novartis Hrvatska d.o.o. Tel: +385 1 6274 220 | Romania Novartis Pharma Services Romania SRL Tel: +40 21 31299 01 |
Ireland Novartis Ireland Limited Tel: +353 1 260 12 55 | Slovenia Novartis Pharma Services Inc. Tel: +386 1 300 75 50 |
Iceland Vistor hf. Tel: +354 535 7000 | Slovakia Novartis Slovakia s.r.o. Tel: +421 2 5542 5439 |
Italy Novartis Farma S.p.A. Tel: +39 02 96 54 1 | Finland Novartis Finland Oy Tel: +358 (0)10 6133 200 |
Cyprus Novartis Pharma Services Inc. Tel: +357 22 690 690 | Sweden Novartis Sverige AB Tel: +46 8 732 32 00 |
Latvia SIA Novartis Baltics Tel: +371 67 887 070 |
Date of last revision of this leaflet:
Other sources of information
Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu
The average price of GALVUS 50 mg TABLETS in October, 2025 is around 31.21 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.